SCHEMBL24569837

SCHEMBL24569837

O=C1c2ccccc2C2(c3ccccc31)c1cc(-c3ccccc3)ccc1N1c3ccccc3Sc3cccc2c31

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCHE P06276 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
APAF1 O14727 1/20 0.33
NPC1 O15118 1/20 0.33
LMNA P02545 1/20 0.33
MAPT P10636 1/20 0.33
THRB P10828 1/20 0.33
XBP1 P17861 1/20 0.33
PTBP1 P26599 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33
GALK1 P51570 1/20 0.33
BLM P54132 1/20 0.33
SMAD3 P84022 1/20 0.33
ATM Q13315 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
PDE6D O43924 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24608666 0.92 BCHE (0.34) BCHEMEN1KMT2AAPAF1NPC1
SCHEMBL24569268 0.92 MEN1 (0.33) BCHEMEN1KMT2AAPAF1NPC1
SCHEMBL24608699 0.90 BCHE (0.33) BCHEMEN1KMT2AAPAF1NPC1
SCHEMBL24569263 0.88 NOX1 (0.36) BCHEMEN1KMT2AL3MBTL1MAOA
SCHEMBL24608614 0.85 MGLL (0.30) BCHEMGLL
SCHEMBL24608726 0.83 HTT (0.34) MEN1KMT2AAPAF1NPC1LMNA
SCHEMBL24608660 0.83 PGR (0.35) MEN1KMT2AAPAF1NPC1LMNA
SCHEMBL24608878 0.83 NPC1 (0.39) BCHEMEN1KMT2ANPC1MAPT
SCHEMBL24608641 0.80 TYMS (0.35) BCHELMNATYMS
SCHEMBL24608700 0.80 BCHE (0.35) BCHEMAPTEDNRBEDNRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917912-B2 Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source CANON KABUSHIKI KAISHA (JP) 2024-02-27 US disclosed
US-11917912-B2 Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source CANON KABUSHIKI KAISHA (JP) 2024-02-27 US disclosed
US-20220216423-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC APPARATUS, ILLUMINATION APPARATUS, MOVING OBJECT, AND EXPOSURE LIGHT SOURCE CANON KABUSHIKI KAISHA (JP) 2022-07-07 US disclosed
EP-4019504-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC APPARATUS, ILLUMINATION APPARATUS, MOVING OBJECT, AND EXPOSURE LIGHT SOURCE CANON KABUSHIKI KAISHA (JP) 2022-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917912-B2 Organic compound, organic light-emitting element, display apparatus, photoelectric conversion apparatus, electronic apparatus, illumination apparatus, moving object, and exposure light source AOX1, SOD1, L1CAM BCHE 2209/4885MEN1 2311/4885KMT2A 2215/4885
US-20220216423-A1 ORGANIC COMPOUND, ORGANIC LIGHT-EMITTING ELEMENT, DISPLAY APPARATUS, PHOTOELECTRIC CONVERSION APPARATUS, ELECTRONIC APPARATUS, ILLUMINATION APPARATUS, MOVING OBJECT, AND EXPOSURE LIGHT SOURCE AOX1, SOD1, L1CAM BCHE 2209/4885MEN1 2311/4885KMT2A 2215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.